Maravai LifeSciences Holdings, Inc. (MRVI) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 65.84M | 49.87M | 41.63M | 47.4M | 46.85M | 56.41M | 65.2M | 73.4M | 64.18M | 74.14M | 66.86M | 68.91M |
| Revenue Growth % | 40.53% | -11.59% | -36.15% | -35.43% | -27% | -23.92% | -2.49% | 6.51% | -18.79% | -63.78% | -65.04% | -71.61% |
| Cost of Goods Sold | 32.14M | 37.62M | 35.98M | 39.63M | 39.13M | 37.44M | 36.83M | 38.27M | 38.34M | 35.11M | 36.69M | 43.27M |
| COGS % of Revenue | 48.81% | 75.45% | 86.42% | 83.61% | 83.51% | 66.38% | 56.48% | 52.14% | 59.73% | 47.35% | 54.87% | 62.79% |
| Gross Profit | 33.7M | 12.24M | 5.66M | 7.77M | 7.72M | 18.96M | 28.37M | 35.13M | 25.84M | 39.03M | 30.18M | 25.64M |
| Gross Margin % | 51.19% | 24.55% | 13.58% | 16.39% | 16.49% | 33.62% | 43.52% | 47.86% | 40.27% | 52.65% | 45.13% | 37.21% |
| Gross Profit Growth % | 336.26% | -35.44% | -80.07% | -77.89% | -70.11% | -51.42% | -5.98% | 37% | -43.01% | -74.23% | -80.29% | -87.51% |
| Operating Expenses | 31.23M | 18.98M | -109.78M | 74.05M | 56.89M | 57.09M | 197.49M | 44.64M | 44.7M | 46.18M | 45.6M | 37.26M |
| OpEx % of Revenue | 47.43% | 38.06% | -263.72% | 156.23% | 121.42% | 101.22% | 302.9% | 60.82% | 69.66% | 62.29% | 68.19% | 54.06% |
| Selling, General & Admin | 27.34M | 15.19M | 78.14M | 38.58M | 39.56M | 41.24M | 39.09M | 40.56M | 40.88M | 38.48M | 38.86M | 35.38M |
| SG&A % of Revenue | 41.52% | 30.47% | 187.7% | 81.39% | 84.45% | 73.12% | 59.95% | 55.25% | 63.7% | 51.9% | 58.12% | 51.33% |
| Research & Development | 3.89M | 3.79M | 9.77M | 4.88M | 4.89M | 4.56M | 4.34M | 5.28M | 5.03M | 4.59M | 4.35M | 4.19M |
| R&D % of Revenue | 5.91% | 7.6% | 23.47% | 10.3% | 10.43% | 8.09% | 6.66% | 7.2% | 7.84% | 6.2% | 6.5% | 6.09% |
| Other Operating Expenses | 0 | 0 | -1000K | 1000K | 1000K | 1000K | 1000K | -1000K | -1000K | 1000K | 1000K | -1000K |
| Operating Income | 2.47M | -6.74M | 115.44M | -66.28M | -49.16M | -38.13M | -169.11M | -9.51M | -18.86M | -7.15M | -15.42M | -11.61M |
| Operating Margin % | 3.76% | -13.51% | 277.3% | -139.84% | -104.93% | -67.6% | -259.38% | -12.96% | -29.39% | -9.64% | -23.06% | -16.85% |
| Operating Income Growth % | 105.03% | 82.33% | 168.26% | -596.78% | -160.65% | -433.29% | -996.93% | 18.1% | -844.61% | -106.54% | -113.19% | -106.43% |
| EBITDA | 15.45M | 8M | 131.28M | -50.89M | -34.25M | -23.6M | -155.07M | 5.04M | -5.11M | 5.83M | -2.32M | 184K |
| EBITDA Margin % | 23.47% | 16.03% | 315.35% | -107.37% | -73.11% | -41.85% | -237.85% | 6.86% | -7.96% | 7.86% | -3.47% | 0.27% |
| EBITDA Growth % | 145.11% | 133.87% | 184.66% | -1110.76% | -570.56% | -504.87% | -6581.39% | 2636.41% | -138.01% | -95.11% | -101.83% | -99.9% |
| D&A (Non-Cash Add-back) | 12.98M | 14.73M | 15.84M | 15.39M | 14.91M | 14.53M | 14.04M | 14.55M | 13.75M | 12.98M | 13.1M | 11.8M |
| EBIT | 2.47M | -56.45M | -38.3M | -67.31M | -45.91M | -35.24M | -162.01M | -4.99M | -11.54M | 671.59M | -8.93M | -6.34M |
| Net Interest Income | -3.88M | -4.17M | 8.46M | -3.79M | -3.55M | -5.23M | -6.56M | -4.85M | -3.65M | -7.94M | -4.21M | -231K |
| Interest Income | 1.87M | 2.38M | 15.31M | 3.03M | 3.23M | 6.04M | 7.07M | 7.09M | 7.21M | 7.46M | 7.43M | 6.79M |
| Interest Expense | 5.75M | 6.55M | 6.84M | 6.82M | 6.78M | 11.26M | 13.63M | 11.94M | 10.86M | 15.4M | 11.64M | 7.02M |
| Other Income/Expense | -9M | -56.27M | -160.59M | -7.85M | -3.53M | -8.37M | -6.53M | -7.42M | -3.55M | 663.34M | -5.15M | -1.75M |
| Pretax Income | -6.53M | -63.01M | -45.15M | -74.13M | -52.69M | -46.5M | -175.64M | -16.93M | -22.41M | 656.19M | -20.56M | -13.36M |
| Pretax Margin % | -9.92% | -126.36% | -108.45% | -156.39% | -112.47% | -82.44% | -269.39% | -23.06% | -34.92% | 885.05% | -30.75% | -19.39% |
| Income Tax | -151K | 6K | -92K | -4.29M | 162K | -7K | 311K | -2.44M | 271K | 766.17M | -5.46M | -1.42M |
| Effective Tax Rate % | 2.31% | -0.01% | 0.2% | 5.78% | -0.31% | 0.02% | -0.18% | 14.39% | -1.21% | 116.76% | 26.56% | 10.63% |
| Net Income | -3.73M | -35.68M | -25.56M | -39.59M | -29.95M | -26.14M | -99.04M | -7.58M | -12.08M | -105.96M | -6.46M | -6.54M |
| Net Margin % | -5.67% | -71.55% | -61.39% | -83.53% | -63.92% | -46.35% | -151.9% | -10.33% | -18.82% | -142.92% | -9.66% | -9.49% |
| Net Income Growth % | 87.53% | -36.47% | 74.2% | -421.96% | -147.93% | 75.33% | -1432.62% | -15.96% | -17926.87% | -381.55% | -114.53% | -109.18% |
| Net Income (Continuing) | -6.38M | -63.02M | -45.06M | -69.84M | -52.85M | -46.49M | -175.96M | -14.49M | -22.68M | -109.98M | -15.1M | -11.94M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 157.52M | 160.33M | 186.42M | 202.12M | 229.66M | 251.92M | 267.99M | 339.48M | 366.73M | 373.13M | 372.99M | 377.07M |
| EPS (Diluted) | -0.03 | -0.25 | -0.18 | -0.27 | -0.21 | -0.18 | -0.70 | -0.06 | -0.09 | -0.80 | -0.05 | -0.05 |
| EPS Growth % | 87.86% | -38.89% | 74.29% | -383.87% | -130.01% | 77.5% | -1328.57% | -12.5% | -795.1% | -221.21% | -106.45% | -103.88% |
| EPS (Basic) | -0.03 | -0.25 | -0.18 | -0.27 | -0.21 | -0.18 | -0.70 | -0.06 | -0.09 | -0.80 | -0.05 | -0.05 |
| Diluted Shares Outstanding | 146.43M | 145.07M | 144.68M | 144.24M | 143.43M | 139.73M | 141.56M | 135.84M | 132.33M | 132.14M | 131.93M | 131.86M |
| Basic Shares Outstanding | 146.43M | 145.07M | 144.68M | 144.24M | 143.43M | 141.81M | 141.56M | 135.84M | 132.33M | 132.14M | 131.93M | 131.86M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |